Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy

NCT05243706 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05243706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2022
Completion date
December 30, 2023
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vinca alkaloid adverse reaction